Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protein profile predicts prognosis for lung cancer

08.08.2003


In the future, many cancer scientists and physicians believe, a "molecular fingerprint" of an individual´s cancer may be used to diagnose that patient´s disease and tailor therapy.



Researchers at Vanderbilt have moved a step closer to that scenario with the identification of a distinct pattern of expression of 15 proteins in lung cancers that can predict a poor prognosis or a good prognosis. All patients in the poor prognosis group had died one year after diagnosis, while all patients in the good prognosis group were still alive. Median survival, the point at which half the patients were still alive, was six months for the poor prognosis group, compared to 33 months for the good prognosis group. "If this pattern is confirmed in larger studies, its prognostic power exceeds that of virtually any previously published standard molecular marker," the authors write in the August 9 issue of The Lancet.

The scientists also demonstrate that protein profiles obtained from a tiny amount of tumor tissue – only 1 millimeter in diameter and only 1/1000 of a millimeter in thickness - can be used to predict risk that the cancer has spread to nearby lymph nodes.


"Involvement of lymph nodes is one of the most important factors in determining treatment strategies, so the clinical implications of these data could be significant," said Dr. David P. Carbone, Ingram Professor of Cancer Research, professor of Medicine and Cancer Biology. "Being able to use molecular markers to divide patients into high- or low-risk groups would also be very useful in determining treatment strategy."

Such a predictor could help patients and families, with their physicians, decide the most appropriate action, which could range from more aggressive therapy at the outset to avoiding therapies that are more likely to hurt quality of life for the patient than to extend that life.

The research involved investigators from the Vanderbilt-Ingram Cancer Center; Vanderbilt School of Medicine´s departments of Medicine, Preventive Medicine, Molecular Physiology and Biophysics, Cardiac and Thoracic Surgery, and Pathology; and Vanderbilt´s Mass Spectrometry Research Center. The project is part of Vanderbilt´s Specialized Program of Research Excellence (SPORE) in lung cancer, a major initiative funded by the National Cancer Institute.

Now that the human genome has been defined, proteomics – the study of the proteins that carry out the work of the cells at the instruction of the genes – is widely considered the next frontier in biomedical research. Vanderbilt has one of the strongest programs in the world in proteomics research, with the sophisticated equipment, informatics power and statistical expertise required to comprehensively analyze the activity of thousands of proteins at once.

The investigators used mass spectrometry and customized software to analyze samples from 79 lung tumors and 14 normal lung tissue. The investigators were able, based on differences in patterns of protein expression, to distinguish with 100 percent accuracy:

  • Lung tumor from normal lung;

  • Primary non-small cell lung cancer (NSCLC) from normal lung;

  • Primary NSCLC from cancer that had spread to the lungs from other organs; and

  • Adenocarcinomas from squamous cell carcinomas, squamous cell carcinomas from large cell carcinomas.

Predictions based on protein profiles were confirmed by pathological evaluation under a microscope. In one case, a large cell carcinoma may have been misclassified based on protein patterns as an adenocarcinoma, but the investigators report that this tumor may actually be an adenocarcinoma that is too poorly differentiated to identify as such under the microscope.

The investigators note that using protein profiles to make distinctions that are already apparent under the microscope offers little use in clinical care, although the approach is potentially useful in identifying novel therapeutic targets. However, the ability to use protein profiles to predict node involvement or to identify patients as high- or low-risk could have great implications for treatment strategies, Carbone said.

"Because such small tissue samples are needed, it would be of great interest to analyze protein expression patterns of tissue samples from needle aspirations or from different cell subtypes within the lung," Carbone said. "It also would be interesting to look for patterns associated with response to specific therapies, with smoking exposure, or with preneoplasia and the progression to cancer.

"If these data are confirmed using larger numbers of patients, this technology could have significant implications for the clinical management of non-small cell lung cancer."

Contact: Cynthia Floyd Manley, cynthia.manley@vanderbilt.edu

Cynthia Floyd Manley | EurekAlert!
Further information:
http://www.mc.vanderbilt.edu/reporter

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>